CVS Health NYSE:CVS, a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but Wall Street still hit the sell button as the stock fell 5.8% in regular trading. Adjusted earnings jumped to $2.58 per share from $1.81 a…
Q2 saw broad-based revenue and earnings growth, with adjusted EPS up over 40% year-over-year and all segments outperforming. Full-year 2026 guidance was raised for EPS and cash flow, and technology investments are driving operational gains. 340B headwinds and Caremark membership declines are expect…
Q2 2026 saw 7.3% revenue growth, adjusted EPS of $2.58, and strong cash flow from operations. Full-year guidance was raised across revenue, EPS, and operating income, with all major segments showing improved performance.Original document: CVS Health Corporation [CVS] Slides Release — Aug. 5 2026Thi…
CVS Health reported strong second-quarter 2026 results with total revenues of $106.1 billion and GAAP diluted EPS of $2.31 (Adjusted EPS $2.58). The company generated year-to-date cash flow from operations of $10.6 billion and raised its full-year 2026 guidance for GAAP diluted EPS to $6.84–$7.04…
WOONSOCKET, R.I., Aug. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.Through CVS Health's connected care mode…
Diversified healthcare company CVS Health NYSE:CVSwill be reporting results this Wednesday before the bell. Here’s what to look for.CVS Health beat analysts’ revenue expectations last quarter, reporting revenues of $100.4 billion, up 6.2% year on year. It was an exceptional quarter for the company…
CVS Health (CVS), UroGen Pharma (URGN), and Crown Holdings (CCK) stocks climbed to 52-week highs on Tuesday as investors focused on operational improvements, commercial progress, and earnings optimism.CVS Health and Crown Holdings stocks ended the session 2% higher, while UroGen Pharma gained over…
Pharmacy-focused sites to open in select communities to help increase access to pharmacy careOpenings are part of ongoing commitment to serve communities and meet consumers where they areWOONSOCKET, R.I., July 17, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today unveiled its first pharmacy-focused…
NORTHAMPTON, MA / ACCESS Newswire / July 8, 2026 / Originally published on CVS Health Company NewsroomKey pointsLiving with HIV today: One patient's experienceWhen Phoenix-based Christopher Hooper was diagnosed with human immunodeficiency virus (HIV) as a college student in the 1990s, treatment opt…
